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Abstract
Background: Natural proteins undergo in vivo spontaneous post-biosynthetic deamidation of specific asparagine residues
with isoaspartyl formation. Deamidated-isomerized molecules are both structurally and functionally altered. The enzyme
isoaspartyl protein carboxyl-O-methyltransferase (PCMT; EC 2.1.1.77) has peculiar substrate specificity towards these
deamidated proteins. It catalyzes methyl esterification of the free a-carboxyl group at the isoaspartyl site, thus initiating the
repair of these abnormal proteins through the conversion of the isopeptide bond into a normal a-peptide bond.
Deamidation occurs slowly during cellular and molecular aging, being accelerated by physical-chemical stresses brought to
the living cells. Previous evidence supports a role of protein deamidation in the acquisition of susceptibility to apoptosis.
Aim of this work was to shed a light on the role of PCMT in apoptosis clarifying the relevant mechanism(s).
Methodology/Principal Findings: Endothelial cells transiently transfected with various constructs of PCMT, i.e.
overexpressing wild type PCMT or negative dominants, were used to investigate the role of protein methylation during
apoptosis induced by oxidative stress (H2O2; 0.1–0.5 mM range). Results show that A) Cells overexpressing ‘‘wild type’’
human PCMT were resistant to apoptosis, whereas overexpression of antisense PCMT induces high sensitivity to apoptosis
even at low H2O2 concentrations. B) PCMT protective effect is specifically due to its methyltransferase activity rather than to
any other non-enzymatic interactions. In fact negative dominants, overexpressing PCMT mutants devoid of catalytic activity
do not prevent apoptosis. C) Cells transfected with antisense PCMT, or overexpressing a PCMT mutant, accumulate
isoaspartyl-containing damaged proteins upon H2O2 treatment. Proteomics allowed the identification of proteins, which are
both PCMT substrates and apoptosis effectors, whose deamidation occurs under oxidative stress conditions leading to
programmed cell death. These proteins, including Hsp70, Hsp90, actin, and Bcl-xL, are recognized and methylated by PCMT,
according to the general repair mechanism of this methyltransferase.
Conclusion/Significance: Apoptosis can be modulated by ‘‘on/off’’ switch partitioning the amount of specific protein
effectors, which are either in their active (native) or inactive (deamidated) molecular forms. Deamidated proteins can also be
functionally restored through methylation. Bcl-xL provides a case for the role of PCMT in the maintenance of functional
stability of this antiapoptotic protein.
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Introduction
Protein deamidation occurs spontaneously in proteins at level of
unstable Asn residues, which are flanked, on the a-carboxyl side,
by small non-bulky residues, such as Gly, Ala, Ser or Thr [1,2].
The deamidation mechanism entails the nucleophilic attack of the
peptidyl nitrogen of the Asn+1 residue onto the b-carbonyl carbon
of the Asn, leading to the formation of an aspartyl succinimidyl
(ASU) intermediate, with the elimination of the ammonia moiety.
(Fig. 1). ASU itself is unstable and its ring can open on either side
of the nitrogen atom, yielding either a normal peptide or an
atypical isopeptide containing a b-linked isoaspartyl residue
(isoAsp) [3,4] the latter form being generally prevalent [4]. The
occurrence of such an abnormal residue can significantly alter
protein structure and function, as it has been demonstrated for
epidermal growth factor, calmodulin, tubulin, synapsin, eye lens
crystallins, Alzheimer’s b-amyloid, tissue plasminogen activator [5]
collagen type-I [6], Protein Kinase A [7] and others.
Protein isoaspartyl carboxyl O-methyltransferase (PCMT;
2.1.1.77) is a S-adenosylmethionine (AdoMet)–dependent methyl-
transferase, which specifically recognizes and methyl esterifies the
free a-carboxyl groups of the isoaspartyl residues, raising from
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conversion of the abnormal L-isoAsp residue into L-aspartyl,
eliminating the isopeptide bond which alters protein conforma-
tion, thus preventing the accumulation of dysfunctional proteins.
This methylation-dependent repair activity has been demonstrated
in vitro, with synthetic isoAsp-containing peptides as well as with
deamidated purified proteins. Various ex vivo studies confirmed
that a PCMT activity is related to the processing of deamidated-
isomerized proteins. For example in the erythrocytes from patients
with spherocytosis [8] or with a G6PD deficiency [9] the increase
in membrane protein isomerization, associated with the disease,
could be monitored ex vivo by an increase in methyl ester formation
in the intact erythrocytes. On the other hand, in chronic renal
failure, where PCMT is inhibited by the intracellular accumula-
tion of S-adenosylhomocysteine, membrane proteins tend to
accumulate isomerized aspartyls within the red cell membrane
[10]. Further in vivo studies provided evidence on the role of this
enzyme in preventing the accumulation of potentially harmful
damaged proteins. In PCMT knockout mice isomerized proteins
increased 4–8 fold compared with the levels detected in the wild-
type mice, and the knockout animals exhibited brain damage and
fatal epileptic seizures [11].
A number of cell stress conditions have been linked to an
increased propensity of proteins to undergo deamidation.
Oxidative conditions have been considered as a way through
which proteins become more susceptible to deamidation. The
underlying mechanism is still unclear, although the evidence
suggests that oxidative conditions may induce an increased
flexibility of the polypeptide backbone or a transient unfolding
of proteins, allowing Asn deamidation and enhancing the
formation of L-isoAsp residues. In this respect it has been shown
that erythrocytes from glucose-6-phosphate dehydrogenase
(G6PD)-deficient patients display a higher propensity to deami-
dation at membrane protein level [9]. Moreover, UV irradiation,
which causes an increased formation of reactive oxygen species,
leads to an increased protein deamidation in cultured melanoma
cells [12]. On the other hand, analysis of the PCMT gene provided
interesting clues about the regulation of this enzyme. This gene
contains several motifs, as potential regulation sites in response to
different stress conditions [13].
It has been proposed that protein methyl esterification,
catalyzed by PCMT, may be able to mediate protection from
apoptosis induced by Bax in a neuronal cell line [14]. This
interpretation relies upon the evidence that cotransfection with a
PCMT carrying vector prevents apoptosis induced by Bax, in this
system. More recently it has been shown that Bcl-xL,a n
antiapoptotic member of the Bcl2 protein family, contains two
labile asparaginyl sites which are deamidation-prone (i.e. positions
52 and 66) [15]. The deamidated Bcl-xL is not more able to block
the action of pro-apoptotic proteins thus leading to cell death. A
transient intracellular alkalinization has been related to Bcl-xL
isomerization during cell stress [16]. It is worth noting in this
respect that general alkaline pH conditions increase the tendency
of labile asparaginyl residues to form ASU. Consistent with these
observations the rate of Bcl-xL deamidation was found to be
significantly reduced in hepatocellular carcinomas compared to
normal liver tissue and this has been linked to a resistance of the
transformed cells to undergo apoptosis [17].
We report here that PCMT, when overexpressed in endothelial
cells, is able to prevent apoptosis induced by an oxidative
treatment. Experiments using PCMT negative dominants show
that the enzymatic activity must be preserved in order to exert its
antiaptotic effect. In order to identify molecular mediators of
apoptotic cascade involved in this mechanism, and specifically
recognized and modified by PCMT, we have employed the
human recombinant enzyme as a specific ligand. We thus
identify in our experimental system, a number of methyltransfer-
ase targets, also including Bcl-xL. We could therefore infer the role
of protein methylation in apoptotic cell death and its underlying
implications.
Figure 1. Mechanism for deamidation of asparaginyl residues in peptides. (Step 1): the nitrogen of the Asn+1 residue (a Gly in the example)
attacks the b-carbonyl carbon of the Asn, thus forming the succinimidyl derivative of the peptide (ASU) with the ammonia elimination. The ASU ring
can open spontaneously on either side of the nitrogen atom. In one case the a-aspartyl peptide is formed (Step 2). In the other case the b-isoaspartyl
peptide does occur (Step 3).
doi:10.1371/journal.pone.0003258.g001
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Characterization of PCMT plasmid constructs
Porcine aortic endothelial cells (PAEC) were transfected with
plasmid constructs carrying the PCMT sense or the antisense genes
or either negative dominant mutants (Asp83RPhe and As-
p83RVal), as described under ‘‘Methods’’. The site of mutagenesis,
which affects a conserved residue in sequence motif I, involved in
AdoMet binding [18,19], was chosen on the basis of the information
available on PCMT structure and on its catalytic mechanism.
PAEC extracts were then used as a PCMT source to check
whether transfection successfully produced the overexpression of
the proper protein species (wild type or mutant) or, in the case of
antisense, silenced the endogenous PCMT. Methyltransferase
activity was assayed, according to the vapor diffusion assay
procedure, in the presence of saturating concentrations of both the
methyl donor AdoMet and ovalbumin, a common in vitro methyl
accepting substrate.
Results in Fig. 2 panel A show that PAEC transfected with the
sense PCMT gene displayed an increased methyltransferase
activity, compared either with the antisense PCMT transfectants
or with both negative mutants.
The same cell extracts were then analyzed by SDS-PAGE and
Western blot, using a PCMT antipeptide antibody. All transfec-
tants carrying PCMT sense (wild type or mutants) over-expressed
the relevant protein, while the protein signal was almost
undetectable in those carrying the antisense counterpart (Fig. 2,
panel B). These results demonstrated that PAEC, transfected with
either PCMT Asp83RPhe or Asp83RVal plasmids effectively
overexpress the relevant mutant proteins, where the conserved
Asp83 residue in the consensus region I is substituted by a residue
with a non polar side chain. As the result, the mutant proteins are
devoid of catalytic activity. Transient transfection of PAEC with a
plasmid carrying the antisense PCMT significantly lowers the
activity of the endogenous methyltransferase, by critically reducing
its expression. Consequently PAEC transiently transfected with
plasmids carrying various PCMT constructs, can be used as a
model system to study the role of PCMT on apoptosis induced by
an oxidative stress.
PCMT overexpression prevents apoptosis induced by
H2O2 treatment in endothelial cells
PAEC transfected with plasmids carrying PCMT wild type,
mutants or antisense, were exposed to an oxidative stress brought
by H2O2 treatment, as described in the experimental section.
Apoptosis was monitored by the occurrence of DNA fragmenta-
tion, according to the typical DNA ladder pattern. In addition,
caspase 3 activation was detected in cell extracts by SDS-PAGE
Western blot analysis using an anti-caspase 3 antibody, which
specifically recognizes the cleaved (activated) form of this enzyme.
The activation of the apoptosis cascade was further confirmed by
checking PARP cleavage, as a typical caspase 3 substrate.
Fig. 3 column A shows the results of the DNA fragmentation
(ladder) detection assay. Treatment with 0.1 mM H2O2 was fully
effective inducing apoptosis in PAEC cells transfected with the
antisense PCMT plasmid, compared with the cells overexpressing
the catalytically active ‘‘sense’’ PCMT. The latter transfectants
were in fact resistant to H2O2 treatment, up to a concentration of
the oxidant in between 0.3 and 0.4 mM. As for the mutants, cells
overexpressing either Asp83RVal or Asp83RPhe PCMT showed
a sensitivity to H2O2 comparable with that observed in the
antisense PCMT transfectants, since 0.1 mM H2O2 is sufficient to
generate an evident DNA fragmentation.
The enhanced sensitivity to the proapoptotic stimulus revealed
by the DNA ladder assay was further confirmed by SDS-PAGE
Western blot experiments, aimed at the detection of caspase-3
activation and poly (ADP-ribose) polimerase (PARP) cleavage
(Fig. 3 column B). In cells transfected with antisense PCMT,
indeed, apoptosis was apparent even at 0.1 mM H2O2 concen-
tration. A similar behavior was observed in cells transfected with
either PCMT mutants, in which apoptosis markers appeared
already at 0.1 mM H2O2 concentration. Conversely, in the sense
PCMT transfectants both markers of apoptosis were detected only
at a H2O2 concentration in between 0.3 and 0.4 mM.
These results, as a whole, demonstrated that PCMT overex-
pression is able to raise the threshold of cell sensitivity to apoptosis
induced by oxidative stress up to a H2O2 concentration
approaching 0.4 mM.
In order to quantitate the effects of the oxidative treatment on
the induction of apoptosis, cells were also analyzed by flow
cytometry. PAEC samples transfected with plasmids carrying wild
type or antisense or negative dominant mutants of PCMT, were
subject to oxidative, pro-apoptotic treatment using 0.3 mM H2O2.
This value, indeed, represented a clear cut off concentration which
was able to induce apoptosis only in the negative dominants
(PCMT antisense or mutants), according to the markers so far
employed. Results of the FACS analysis basically confirmed that
overexpression of wild type PCMT prevents apoptosis induced by
an oxidative stress, as judged by the appearance of a pre-G0 peak
in both the antisense and mutant PCMT cell samples, upon H2O2
treatment (Fig. 3 column C). The evaluation of the area under the
peaks allowed a quantitative assessment of the different cell
Figure 2. Characterization of PCMT plasmid constructs. Panel A)
Plasmids were transfected into endothelial cells and 48 h later
methyltransferase activity was assayed using a methanol diffusion assay
in the presence of saturating concentrations of the methyl donor AdoMet
and ovalbumin as a methyl accepting protein. Results are given as the
meanofthreeexperiments.Errorbarsindicatestandarddeviation;(*)refer
to statistically significant differences (p,0.05), as evaluated by t-test.
Panel B) Cells transfected were then processed for immunoblotting with
PCMT antibody. The immunoblot was reprobed for actin as a loading
control.Thesample‘‘PCMT’’isauthentic humanrecombinant enzyme as a
positive control. PAEc=PAE transfected with void plasmid.
doi:10.1371/journal.pone.0003258.g002
Protein Repair and Apoptosis
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DNA ladder in cells overexpressing PCMT constructs and subject to oxidative treatment. Apoptotic DNA ladder patterns, of transfected endothelial
cells stimulated with different concentrations of H2O2, were detected after transfection with plasmid void (control) or carrying PCMT wild type (sense);
antisense PCMT; PCMT Asp83 RPhe83 Mut and PCMT Asp83 RVal83 Mut. Column B: Caspase-3 activation and PARP cleavage in cells overexpressing
PCMT constructs and subject to oxidative treatment. Immunoblot developed with a polyclonal antibody against caspase-3 and PARP (a final effector
of various apoptotic pathways) on transfected endothelial cells stimulated with different concentration of H2O2 after transfection with plasmid void
(control) or carring PCMT wild type (sense), antisense PCMT, PCMT Asp83 RPhe83 Mut and PCMT Asp83 RVal83 Mut. CP is a positive control obtained
by treating a parallel cell sample with cisplatin. Column C: Flow cytometry analysis of cells overexpressing PCMT constructs and subject to oxidative
treatment. Cells stimulated with 0.3 mM of H2O2 after transfection with void plasmid (control), PCMT wild type (sense), Antisense PCMT, PCMT Asp83
RPhe83 Mut. PCMT Asp83 RVal83 Mut. PI: propidium iodide.
doi:10.1371/journal.pone.0003258.g003
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PCMT renders cells resistant to apoptosis, while a high percentage
of cells transfected with antisense or either negative mutants
undergo apoptosis upon H2O2 treatment.
Accumulation of deamidated isoaspartyl-containing
proteins in PCMT negative dominants
It is conceivable that the reduced PCMT activity in PAEC
transfected with antisense or PCMT mutants may determine a
significant build up of isoaspartyl-containing damaged proteins.
Therefore we attempted: a) to establish whether or not PCMT
overexpression was able to prevent the accumulation of deam-
idated-isomerized proteins, in PAEC upon oxidative pro-apoptotic
treatment; b) to quantitatively evaluate the amount of isoAsp sites
in proteins extracted from these cells. To this end an in vitro assay,
using recombinant PCMT, was employed.
Results showed that transiently transfected PAEC were all
characterized by a high content of deamidated proteins, except
those overexpressing the wild type PCMT gene (Fig. 4). Therefore,
the ability of PCMT to prevent apoptosis upon oxidative
treatment was strictly dependent on the retention of its catalytic
activity. In fact negative dominants, carrying a point mutation
involving the catalytic site of the enzyme, accumulated isomerized-
damaged proteins and, hence, were more sensitive to the pro-
apoptotic stimulus. These results led us to exclude that PCMT
may prevent apoptosis though a direct interaction of the enzymatic
protein with members of the apoptotic cascade. Such a direct
interaction mechanism is instead operative in E. Coli, where PCMT
overexpression improved heat shock survival by a mechanism
independent of its methyltransferase activity [20].
More remarkably, our results demonstrate that some molecular
mediators, involved in apoptosis induced by pro-oxidant condi-
tions, are deamidated proteins, which can be methylated by
PCMT, since they contains the unique feature recognized by this
enzyme: the isoaspartyl residue. We were then prompted to search
for substrates of PCMT whose deamidation could be favored
under oxidative pro-apoptotic conditions and which could no
longer be ‘‘repaired’’ in the negative dominants.
Identification of PCMT substrates
In order to identify specific methyl accepting substrates involved
in apoptosis, the purified human recombinant PCMT was cross-
linked with sulfo-SBED, a trifunctional reagent containing a
biotin, a sulfonated N-hydroxysuccinimide (Sulfo-NHS)active ester
and a photoactivatable aryl azide. The moiety containing the
active ester also exhibits a cleavable disulfide bond. A PCMT-
interacting substrate is then captured by the photoreactive aryl
azide moiety. The interacting complex is then isolated and the
disulfide bond subsequently reduced. Upon reduction of the
disulfide bond, PCMT is released and biotin is ‘‘transferred’’ onto
the methyltransferase substrate (Label Transfer Method) [21]
(Fig. 5 panel A). The biotinylated PCMT substrates can then be
purified exploiting streptavidin-biotin interactions as described
under ‘‘Methods’’ and subject to proteomic analysis. As an
expression system, we chose human umbilical vein endothelial
cells (HUVEC) infected with retrovirus carrying antisense-PCMT
at a moi of 100. The retroviral transgene was expressed in nearly
100% of the cells, as assessed by confocal microscopy of GFP
fluorescence. We used real time-PCR to analyze the silencing of
PCMT gene in the cells infected with antisense-PCMT carrying
virus. PCMT was effectively hypoexpressed in the antisense
PCMT-transduced cells Relative expression of PCMT in the
HUVEC infected with the vector carrying the antisense PCMT
was 0.012 fold (60.0035; standard deviation) compared to what
detected in the uninfected HUVEC. HUVEC infected with retro-
PCMT antisense were then treated with 0.3 mM H2O2 for 24 h.
In order to identify PCMT substrates, protein extracts from these
cells were incubated with biotinylated human recombinant
PCMT, as above described. In order to discriminate the
specifically PCMT-interacting proteins from a background of
non-interacting proteins, a parallel assay was run, as a negative
control, by incubating cell extracts with sulfo-SBED not cross-
linked with PCMT. The resulting protein samples, enriched in
PCMT substrates, were analyzed with 2D gel (Fig. 5 panel B).
Protein spots, differentially expressed between sample and
negative control, were considered for MALDI-TOF mass spectral
analysis. Good matches were found for eight spots that were
analyzed by mass spectrometry. All of them produced a good Z
score, high sequence coverage and had molecular weights and
isoelectric points consistent with the location of the protein on 2D
gel. Several spots could not be identified, since relevant mass data
did not yield a match with a high Z score or good sequence
coverage (Table 1).
Previous work amply demonstrated that two structural features
are essential for PCMT function: a) presence of an isoAsp residue;
b) recognition by the methyltransferase. As for the first feature, the
most deamidation-susceptible residues are asparagines followed by
non bulky residues [1,2,22]. As for substrate-PCMT interaction,
negative structural requirements are the presence of Cys or
charged residues immediately following isoAsp [23] as well as N-
terminal isoAsp residues [24]. Based on these criteria we therefore
carefully reviewed published sequences of all proteins substrates
we had identified. Results confirmed that all proteins indeed
contained at least one deamidation site, thus allowing us to predict
the position at which the actual methylatable isoaspartyls may
occur. Protein disulfide isomerase (accession no P30101) displays
one theoretically deamidation-susceptible site at Asn199Gly,
another at Asn272Ala, plus two adjacent AsnThr sites at position
88. Molecular chaperone HSP70 [accession number (AN)
NP_005338.1] contains several theoretical deamidation sites
including: five Asn-Ala (at position 59, 280, 367, 515, 619), two
Asn-Ser (407, 646), Asn62Thr. Asn41Ser occurs in HSP90 (AN
NP_031381.2). Ferrochelatase (AN NP_000131.1) displays three
Figure 4. Quantitation of the extent of protein deamidation in
cells lysates after oxidative stress. Cells transfected with PCMT wild
type (sense), antisense PCMT (anti), PCMT mutants [Asp83 RPhe83 (Phe)
and Asp83RVal83 (Val)] and endothelial cells transfected with void
plasmid (PAE) were stressed with 0.3 mM of H2O2. Deamidated proteins
were quantitated in each lysate preparation using recombinant PCMT.
Standard deviation error bars are included for each analysis.
doi:10.1371/journal.pone.0003258.g004
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mitochondrial import receptor (AN NP_064628.1) the only
theoretical deamidation site is Asn124Thr. Actin (AN P63261)
contains the following theoretically deamidation-susceptible as-
paragines: Asn12Gly, Asn-Thr at positions 128 and 296,
Asn280Ser. In addition, we identified, as a PCMT substrate, the
cleaved form of the antiapoptotic protein Bcl-xL [25]. Bcl-xL
deamidation sites have been experimentally and unambiguously
identified by previous work, as discussed below. It is now clear that
this protein undergoes deamidation at two (Asn52 and Asn66) of
the three Asn-Gly sequences, which are theoretically sensitive hot
spots for this post-biosynthetic modification. Present results
demonstrate that this protein actually is recognized by the repair
methyltransferase PCMT.
Discussion
Our data demonstrate that PCMT overexpression confers
resistance to apoptosis, induced by oxidative stress, in endothelial
cells. Conversely, under conditions in which PCMT was
suppressed, cells accumulated isoaspartyl-containing, deamidated
proteins, upon oxidative stress. The identification of isoaspartyl-
containing derivatives as the actual target-substrate for this
protection was made possible by the utilization of PCMT as a
specific enzymatic probe, which selectively recognizes the
isoaspartyl moiety in deamidated proteins. In fact we were able
to show that isomerized proteins increase significantly in the cells
committed to apoptosis as the result of oxidative treatment. To
clarify the mechanism involved in this resistance we employed a
Figure 5. Identification of PCMT substrates. Panel A: Experimental strategy for isolation and characterization of PCMT substrates. Step 1:
human recombinant PCMT, purified to homogeneity, was immobilized onto sulfoSBED by N-hidroxysuccinimide chemistry; Step 2: cell extracts as a
source of substrates were added and Step 3: proteins interacting with PCMT were immobilized upon UV photoactivation; Step 4: PCMT was released
and biotin ‘‘transferred’’ onto the methyltrasferase substrate (Label Transfer Method); Step 5: purification was accomplished by exploiting
streptavidin-biotin interactions. Panel B: 2D gel electrophoresis imaging of comparative proteomics. HUVEC were infected with antisense PCMT
carrying retrovirus and then stressed with 0.3 mM of H2O2. Cells lysates were reacted with Sulfo-SBED previously cross-linked with recombinant PCMT
(Panel B). Arrows indicate the protein spots which have been characterized as reported in Table 1. Background noise due to aspecific binding was
subtracted by comparison with the 2D image obtained from a parallel sample reacted with non-cross-linked Sulfo-SBED.
doi:10.1371/journal.pone.0003258.g005
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isolate deamidated-isomerized protein substrates. We can con-
clude that all the proteins we were able to isolate act as
endogenous substrates for PCMT, under conditions in which cells
undergo apoptosis. These substrates include various stress
proteins (HSP70, HSP90, mitochondrial import receptor, protein
disulfide isomerase), the cytoskeletal component actin (a long-
established substrate for PCMT), ferrochelatase and Bcl-xL. The
role in apoptosis of some of these proteins has been well
established, in particular regarding chaperone HSP70 and HSP90
[26]. As for HSP70, this protein prevalently exerts antiapoptotic
activity, both in the intrinsic and in the extrinsic pathways,
according to a complex pattern throughout the apoptosis cascade
[27,28]. As for HSP90, this component, as well, is endowed with
antiapoptotic activity through a multifaceted mechanism [27,29].
Bcl-xL is perhaps the most interesting protein we were able to
isolate, for at least two reasons: first it exerts powerful and direct
antiapoptotic activity. Second, and more relevant to our aim, Bcl-
xL undergoes deamidation in relation with cell damage, giving
rise to its isoaspartyl derivative, and this process has profound
implications on its functional antiapoptotic role. In fact it has
been previously reported in the literature that Bcl-xL deamidation
is critical in the signaling pathway leading from DNA damage to
apoptosis. Data accumulating over the last few years led to the
notion that Bcl-xL deamidation induces a profound structural
modification, which, in turn, hampers the antiapoptotic function
of this protein. In particular Deverman and coworkers used
constructs where Asn52 and Asn66 in the wild type form of Bcl-
xL, the two critical deamidation-susceptible asparagines, are
replaced [15]. Results, as rediscussed subsequently, were
consistent with the view that Asn deamidation to isoaspartate,
as the real product, results in the loss of Bcl-xL function (Erratum
for [15] in [30]. The mechanism for generation of the isoaspartyl
derivative of Bcl-xL has been finally elucidated, as it involves an
increase of the intracellular pH, consequent to cell injury, and
transcriptional activation of a Na/H antiport, which constitutes a
favorable microenvironment for asparaginyl deamidation through
ASU formation [16].
It is worth noting that an oxidative stress, as the means we used
to induce apoptosis, also represents a protein deamidation-
favoring microenvironment. In this respect, it has been previously
shown that a) human erythrocytes treated with either t-BHP or
H2O2 accumulate deamidated isomerized proteins in the cell
membrane, which are methyl esterified ex vivo by PCMT [31]; b)
human erythrocytes from G6PD-deficient subjects are particularly
prone to undergo deamidation at membrane protein level, upon
oxidative stress, compared to normal red cells [9]; c) melanoma
cells also accumulate PCMT substrates upon UV irradiation,
according to a mechanism which is mediated by an oxidation [12].
Finally, we detected increased isoaspartyl formation in the
erythrocytes from patients with Down Syndrome, a condition
which is characterized by increased oxidative stress [32].
Now a more general question arises: is the occurrence of
isoaspartyls upon deamidation a built-in destruction device or,
rather, a fine tuning system acting in concert with methylation? The
presence of deamidation-susceptible Asn in proteins appears to be
selected against during evolution [33]. Some early experimental
evidence [34,35] supports a ‘‘Molecular Clock’’ hypothesis.
According to this model, the presence of such deamidation-
susceptible Asn may account for the occurrence of time-dependent
structural modifications of functional meaning. For example, in the
case of triosephosphate isomerase and serine hydroxymethyltrans-
ferase, deamidation of labile asparagines residues may represent
specific signals for commitment of protein to degradation.
On the other hand, it has been suggested that the non-random
distribution of such labile residues in proteins may not only be
related to their degradation. It has been argued that although
deamidation could be actually considered as a ‘‘structural alter-
ation’’,atleastinsomeinstances,thepersistenceofsuchdeamidation
hot spots during evolution may otherwise serve to certain functions
[5]. According to this view, deamidation may be interpreted as a
molecular switch that regulates partitioning over time between two
molecule subpopulations of a certain protein, which are also
functionally modified. The existence of PCMT, as an enzyme
involved in the ‘‘repair’’ of the isopeptide bond resulting from Asn
deamidation, is also in agreement with the latter mechanism. In this
Table 1. PCMT substrates identified in endothelial cells.
Spot no Protein Information and Sequence Analysis Tools (T) % pI kDa Est’dZ Function
S1 T gi|2507461|pir||P30101 protein disulfide-isomerase (EC 5.3.4.1) ER60
precursor - human
29 6.1 57.06 2.43 Thioreductase/isomerase activity
S19 T gi|16507237|ref|NP_005338.1| heat shock 70 kDa protein 5 (glucose-
regulated protein, 78 kDa); Heat-shock 70 kD protein-5 (glucose-
regulated protein, 78 kD); heat shock 70 kD protein 5 (glucose-regulated
protein, 78 kD) [Homo sapiens]
36 5.1 72.43 2.39 Chaperone
S20 T gi|20149594|ref|NP_031381.2| heat shock 90 kDa protein 1, beta; heat
shock 90 kD protein 1, beta; Heat-shock 90 kD protein-1, beta [Homo
sapiens]
29 5.0 83.59 1.97 Chaperone
S5 T gi|4557593|ref|NP_000131.1| ferrochelatase [Homo sapiens] 53 9.3 48.39 2.01 ferrochelatase activity
S10 T gi|9910382|ref|NP_064628.1| mitochondrial import receptor Tom22
[Homo sapiens]
25 4.3 15.50 2.32 receptor activity
S12 CAA80661 Homo sapiens Bcl-xL 25 5.4 17.10 2.41 anti-apoptosis
S 14 T gi|54036678|pir|P63261| gamma-actin [Homo sapiens] 39 5.3 41.99 2.43 Cytoskeletal structure and
dynamics
S18 T gi|229674|pdb|1ALD| Aldolase A (E.C.4.1.2.13) 18 8.8 39.73 2.43 Energy metabolism
HUVEC cells were infected as described under ‘‘Methods’’. The antisense negative dominants were treated with 0.3 mM H2O2. PCMT ligands were isolated by means of
human recombinant methyltransferase immobilized onto SulfoSBED. Purification, 2D separation and MS analysis were accomplished as detailed in the online
supplemental material.
doi:10.1371/journal.pone.0003258.t001
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which are susceptible to recognition and repair by PCMT, has
been found to occur in the extracellular matrix [36,37]. More
recentlyithas beenreportedthatdeamidation ofsusceptibleproteins
in the extracellular matrix may also serve as a molecular signal to
unravel new integrin binding sites [38]. Deamidation of Bcl-xL, with
consequent abolishment of its antiapoptotic function, thus represents
a further example of such a molecular device to change functional
properties of those proteins in which it occurs. Based on present
results we then propose that PCMT is involved in the modulation of
the apoptotic process, by regulating the balance, within the cell,
between the isoaspartyl-containing and the repaired aspartyl form of
Bcl-xL (Fig. 6). The repair mechanism, as it has been shown on
various models, does not consist in the restoration of the asparaginyl
residues, but, rather, in the conversion of the isopeptide bond at the
level of the isoAsp into a normal a–peptide bond [1,2].
Present results allow us to speculate on the possible implications of
deamidation and methylation in the modulation of programmed cell
death, under conditions in which this process is altered, such as in
cancer. Some of the proteins we thus identified as PCMT substrates,
which are known to be involved in apoptosis, have been implicated
inpathogenesisoftumors,with particularregardtothe acquisition of
resistance by the transformed cell phenotypes. In this respect, it has
been recently reported that HSP70 increases tumorigenicity and
inhibits apoptosis in pancreatic adenocarcinoma [39]. Data also
showed theroleofHSP90 inthemechanismof metastasis [40]about
the involvement of apoptosis in cancer, Bcl-xL perhaps provides the
best example of how methylation of deamidated proteins may play a
role in maintaining full functioning antiapoptotic proteins (Fig. 6).
Theselatter,inturn,maycontributetotheresistanceoftransformed,
tumor cells, which otherwise would undergo programmed death. In
line with this interpretation are previous results showing a significant
reduction in the deamidation rate of Bcl-xL hepatomas, compared to
normal liver tissue [17]. Our present results, on the ability of PCMT
to recognize and methylate Bcl-xL, thus preserving the antiapoptotic
features of this protein, in fact suggest a role of this methyltransferase
as a potential target for anticancer intervention.
Materials and Methods
Materials
The plasmid encoding the GFP was from Stratagene (USA). E.
Coli strain DH5a was used as a host for the plasmids and cloning
procedures, and BMH71-18 mutS was used in the mutagenesis step
(Clontech, Palo Alto, CA, USA). Bl21, Sulfo-SBED and Immuno-
pure immobilized monomeric avidin beads were purchased from
Pierce(Rockford,IL,USA).DTT,ACTH,Renin,andAngiotensinI
were from Sigma (St. Louis, MO, USA). DMEM, RPMI and FBS
were purchased from Life technologies (Invitrogen S.R.L., Milan,
Italy). Trypsin sequencing grade (Product number V5111) was from
Promega (Madison, Wisconsin, USA). Protein standards and
Iodoacetamide were from BioRad laboratories (Milan, Italy). Water
and Acetonitrile were HPLC grade (Sigma). S-adenosyl-L-
[methyl-
14C]Met [specific activity (sp. act.) 50 mCi/mmol] was
purchased from Amersham International (Buckinghamshire, UK).
S-adenosyl-L-[methyl-
3H]Met (sp. act. 500 mCi/mmol) and S-
adenosyl-L-[methyl-
14C]Met (sp. act. 50 mCi/mmol) were pur-
chased from Amersham International (Little Chalfont, Buckingham-
shire, UK). All standards and reagents were from Sigma Chemical
Co. and were of the purest grade available.
PCMT clone
The pBluescript II SK-based plasmid construct pDm2X,
containing human PCMT isoform II cDNA, and polyclonal
antibodies against the C-terminal dodecapeptide of PCMT were
generously provided by Dr. Steven Clarke (Department of
Chemistry and Biochemistry and the Molecular Biology Institute,
University of California Los Angeles, Los Angeles, CA).
Cell Culture and Transient Expression
PAEC were grown on 24–well plates, in DMEM supplemented
with 10% FCS and 16 penicillin/streptomycin. Cells were
maintained at 37uC in humidified air with 5%CO2 atmosphere.
For transient transfection by electroporation, PAEC growing in
150 cm
2 flasks were tripsinized before confluence, collected by
centrifugation, washed with PBS and resuspended in 20 mM
HEPES buffer at pH 7.4, containing 137 mM NaCl, 5 mM KCl,
0.7 mM NaH2PO4 6 mM glucose, at 4uC.
HUVECs from American Type Culture Collection were
maintained in RPMI 1640 with 10% FCS and 2 mM glutamine,
and were used at passages 5 to 10. Co-transfections were
performed by mixing 15 mg of each pcDNA3.1 construct and
2 mg EGFP control. Cells were exposed to a pulsed electric field
that corresponded to a field strength of 0.75 kV/cm and a
duration ranging from 9 to 12 ms using electroporation cuvette
and Gene Pulser II (Bio-Rad Laboratories, Hercules,. CA, USA).
Samples were incubated on ice for a further 5 min, then
transferred to a 10 cm diameter tissue culture dish and incubated
at 37uC under standard growth conditions. After transfection, cells
were plated for 16 h in DMEM supplemented with 10% FCS.
Medium was replaced after 24 h.
Mutagenesis
Mutagenesis was performed by Transformer Site-Directed
Mutagenesis kit from Clontech (Palo Alto, CA). Of the three
highly conserved methyltransferase sequence motifs we chose to
perform mutagenesis of the invariable aspartyl site within sequence
motif I (ALDVGSGSGI), involved in the AdoMet binding site
[18,19]. The mutagenesis primer was 59-ggagctaaagctcttttcgtag-
gatctgg-39, (Asp replaced by Phe); 59 ggagctaaagctcttgtcgtag-
gatctgg39 (Asp mutated into Val). The selection primer was 59-
caggaaagaagatctgagcaaaag-39. A unique restriction site (AflIII) was
Figure 6. Proposed role of Bcl-xL deamidation and methylation
in apoptosis. Deamidation-isomerization of two critical Asn residues
of Bcl-xL abolishes its antiapoptotic function. Methylation of the same
residues can restore the functional integrity of Bcl-xL through repair of
the isopeptide bonds. Regulation of apoptosis toward antiapoptosis is
gained through fine balancing of Bcl-xL deamidation and methylation.
doi:10.1371/journal.pone.0003258.g006
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double-stranded plasmid DNA by the Sanger method was used to
confirm the desired nucleotide substitution.
Characterization of PCMT plasmid constructs
PCMT activity in endothelial cells transfected with vectors
carrying PCMT sense or antisense or either mutants, was detected
by means of the radiochemical assay described by Macfarlane, using
ovalbumin as a standard methyl-accepting substrate [41]. One
enzyme unit is defined as 1 pmol methyl groups transferred6min
21.
Plasmids
pcDNA3.1 wild type. Construction of mammalian
expression plasmid encoding human PCMT was subcloned from
construct pDM2X used for mutagenesis, into pcDNA3.1, using
the KpnI and HindIII restriction sites.
pcDNA3.1 antisense. The cDNA was subcloned from
pcDNA3.1 wild type.
pcDNA3.1 mut phe. pcDNA3.1 encoding for mutated
PCMT Asp83RPhe was subcloned from construct pDM2X mut
Phe into pcDNA3.1 using the KpnI and HindIII restriction sites.
pcDNA3.1 mut Val. pcDNA3.1 encoding for mutated
PCMT Asp83RVal was subcloned from construct pDM2X mut
Val into pcDNA3.1 using the KpnI and HindIII restriction sites.
Apoptosis Assay
Endothelial cells were grown to 70% to 80% confluence and
incubated for 18 h in the absence or the presence of 0.1, 0.2, 0.3,
0.4 or 0.5 mM H2O2. Parallel samples were treated with 35 mM
Cisplatin for 18 h as a positive apoptosis control. The optimal
active H2O2 concentration and exposure time were selected by
determining dose-response and time curve. Under these condi-
tions, the assay was linearly dependent on H2O2 concentration
and incubation time. Longer incubation periods or higher H2O2
concentrations resulted in massive cell death. Apoptosis was
assayed in vitro by a combination of three distinct approaches on
endothelial cells transfected with vectors carrying PCMT sense or
antisense or either mutants.
Caspase-3 activity and PARP cleavage. After oxidative
injury, cells were collected and lysed in the appropriate buffer.
Total cell extracts (30 to 50 mg) were electrophoresed onto a 12.5%
SDS-PAGEgelsystemand transferred onto polyvinylidenedifluoride
membrane (Millipore S.p.A, Milan, Italy). Blots were incubated with
a polyclonal anti-caspase-3 antibody (BD-PharMingen Milan, Italy),
or mouse polyclonal antipoly (ADP-ribose) polimerase (PARP).
Total active caspase-3 and PARP bands were revealed by
chemiluminescence (Amersham-Pharmacia Biotech).
DNA ladder. Cells treated as above were harvested and DNA
was extracted using the Apoptotic DNA ladder Kit (Roche
Diagnostics S.p.A., Monza, Italy). DNA Ladder profiles were
detected upon electrophoresis on 2% agarose gel.
FACS scan analysis. Six hours after the removal of the
stimulus, apoptosis was checked by detected fluorescence
microscopy. FACS analysis (FACSCalibur; Becton-Dickinson,
San Jose, CA, USA) was performed after treating cells pellets
(approx 10
6 cells) with 50 mg/ml propidium iodide (PI) in 0.1%
sodium citrate, in the presence of 0.1% Nonidet P40 and 100 mg/
ml Dnase-free RNase A (Boeringer Mannheim, Milan Italy).
Integration of area under the pre-G0 peak was measured to
quantify percentages of apoptotic cells.
Human recombinant PCMT purification
E. Coli strain DH5a was used for cloning and propagation of
plasmid constructs. For PCMT overexpression, E. Coli strain BL21
(DE3) was transformed with pDM2x expression plasmid and
grown in Luria-Bertani medium, in the presence of 100 mg/mL
ampicillin. PCMT was purified from transformed bacteria
basically as described by MacLaren and Clarke 1995 [42], except
that the original DEAE-cellulose chromatography final step, under
non-equilibrium conditions, was replaced by Q-Sepharose HP
chromatography, using a Hiload 26/10 column (Pharmacia,
Uppsala, Sweden). Column was equilibrated with buffer A
(20 mM Tris-HCl, 0.2 mM EDTA disodium salt, 10% wt/vol
glycerol, 15 mM beta-mercaptoethanol, 25 mM phenylmethylsul-
fonyl fluoride, 0.1 M NaCl, pH 8.0). After sample loading (10 mL,
6 mg/mL protein concentration), the column was washed with 10
volumes of buffer A (at 1 mL/min flow rate), followed by a linear
gradient from 0.1 to 0.7 M NaCl over 210 minutes.
Quantitation of isoaspartyl residues in cells lysates after
oxidative stress
Cells transfected with PCMT wild type (sense), antisense
PCMT, PCMT mutants (Asp83 RPhe and PCMT Asp83RVal)
and untransfected endothelial cells were stressed with 0.3 mM of
H2O2. Deamidated proteins were detected in each lysate
preparation by an in vitro assay using recombinant PCMT.
Damaged residues were specifically recognized and methyl
esterified by PCMT, using radiolabeled AdoMet as the methyl
donor, under conditions designed to insure complete labeling, on a
1:1 molar ratio, of accessible damaged residues in proteins. This
method has proven highly sensitive, specific, reproducible, and
particularly suitable when analysis of deamidated protein mixtures
is to be carried out [43].
Identification of PCMT substrates
In order to identify specific PCMT substrates, HUVEC were
infected with PCMT antisense and stressed with 0.1 mM H2O2.
Cell lysates were prepared as above and analyzed by 2D-gel
electrophoresis according to Zhu et al [44].
Generation of the retrovirus
An 800-bp genomic sequence including either wild type PCMT or
its antisense counterpart was cloned upstream from the IRES of the
MSCV-IRES-GFP (MIGR) (murine stem cell virus-internal ribo-
some entry site-green fluorescent protein) retrovirus. Infectious
defective virionswere transientlyproduced bytransfection of the 293
FT cell line with 3 plasmids: pCMV gag-pol, pCMV-VSV-G
(vesicularstomatitevirusenvelopeglycoprotein).Briefly,293FTcells
were seeded at a concentration of 10
6 cells per well in 6-wells plates.
The next day, 0.5 mg of each plasmid was cotransfected using Exgen
reagent (Euromedex, Mundolshein, France) according to the
manufacturer’s recommendations. Supernatants were collected after
48, 72, and 96 h and concentrated 20-fold over an amicon
membrane (Centricon Plus-80; Millipore, St-Quentin en Yvelines,
France). Viral titers were determined by limiting dilution assay on
NIH 3T3 cells. GFP fluorescence was analyzed by flow cytometry.
Virus stocks containing 10
7 infectious particles per milliliter or more
were used to infect HUVEC (ATCC- CRL-1730).
Quantitative real-time -PCR
RNA was extracted from the antisense PCMT-transduced cells
and non-transfected HUVEC by a double Trizol- chloroform
treatment and precipitated in isopropanol. Total RNA. 250 ng,
was reverse transcribed using the Superscript II (Invitrogen),
where the reaction mixture contained forward primer for PCMT
(59- TTAAAGCCCGGAGGAAGATT39) and, as the reverse, the
oligodT examer included in the kit.
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16SYBR green by for quantification by real time PCR. using an
iCycler iQ machine (BiorRad, inc.); primers pairs used were 59-
TTAAAGCCCGGAGGAAGATT39 and 59-ATCACTTC-
CACCTGGACCAC-3, designed to amplify 169 bp region of
PCMT cDNA.
Relative expression was calculated using the DCt method. To
determine the quantity of PCMT transcript present in the
antisense-PCMT-infected HUVEC, relative to uninfected ones,
their respective Ct values were first normalized by subtracting the
Ct value obtained from the evaluation of the GAPDH transcript,
chosen as an housekeeping gene (DCt=CtPCMT2CtGAPDH). The
relative abundance of PCMT transcript in the infected HUVEC
compared with uninfected cells was calculated by subtracting the
normalized Ct values obtained for uninfected cells from those
obtained from antisense-PCMT infected cells (DDCt=DCtinfec-
ted2DCtuninfected; the relative expression was then determined
(2
2DDCt). The the value of 2
2DDCt.1 reflects increased expression
of the target PCMT gene, and a value of 2
2DDCt,1 points to a
decrease in the gene expression [45].
Crosslinking reaction
PCMT was dissolved at 1 mg/mL in phosphate buffer (0.1 M
phosphate, 0.18 M Na, pH 7.5).1.12 mg of SulfoSBED was weighed
and dissolved in DMSO under subdued light immediately before use.
PCMT and sulfoSBED solutions were combined and maintained
under subdued light with aluminum foil wrapping for 30–60 min at
room temperature and nonreacted SulfoSBED was removed from
solution by dialysis using Slide-A-Lyzer Dialysis Cassette (Pierce).
5 mg of proteins extracted from HUVEC cells line after infection
with PCMT antisense carrying retrovirus and treated for 24 h with
0.1 mM H2O2, were dissolved in 0.5 ml PBS and incubated at room
temperature for 3–5 minutes with the biotinylated complex. A
365 nm UV lamp (Rad-Free Model RF UV-365, Schleicher and
Schuell, Keene, NH, USA), held at 5 cm distance from sample
solutions, was used to activate the arylazide portion of the crosslinker.
Samples were reduced by adding DTT to a final concentration of
50 mM and incubating for 1 h at room temperature.
Binding biotinylated proteins
Avidin affinity capture of biotinylated species was performed
using immobilized monomeric avidin. Small batches (typically
100 ml) of beads in 50% aqueous suspension (MagPrep Strepta-
vidin Beads purchased from Novagen, Merck chemicals Ltd,
Nottingham, UK) were prepared for use into a clean 1.5 ml
microcentrifuge tube and placed in magnetic tube rack, following
wash with 400 ml of 0.1 M phosphate buffer (pH 7.5, 0.18 M Na)
and the aqueous supernatant removed. The beads were washed
twice and resuspended to their original volume then incubated for
30 min at RT with purified biotinylated target protein. After the
binding, the excess of protein was taken away by magnetizing the
beads and removing the aqueous phase.
2D analysis and MALDI-TOF
Gels were stained with Coomassie blue and spots of interest
were identified by comparing gel images as appropriate. Spots of
interest were then cut and submitted to the Proteomics Core. The
samples were transferred to the MassPrep station for automated
in-gel protein digestion, following the protocol included with the
WinPREP Multiprobe II software (WinPREP Multiprobe II;
Perkin Elmer, Massachussets, USA). Briefly, gel pieces were de-
stained with ammonium bicarbonate/acetonitrile and reduced
with dithiothreitol. The reducing mixture was removed and
iodoacetamide in ammonium bicarbonate added and incubated
for 20 min at 37uC. The alkylation solution was removed, followed
by washing with ammonium bicarbonate/water and dehydration
with acetonitrile. In-gel digestion of the extracted proteins was
carried out with 6 ng/mL trypsin in 50 mM ammonium
bicarbonate for 5 h at 37uC. The digested peptides were extracted
in a mixture of 1% formic acid/2% acetonitrile and applied onto a
stainless steel MALDI plate (Micromass). Mass spectra of the
resulting peptides were recorded on the MALDI-TOF spectrom-
eter in reflectron mode (Perkin Elmer Mass Prep Station;
Micromass Maldi-TOF RL). Prior to data collection, calibration
was performed with Angiotensin I (Average molecular mass
1296.5 Da), Renin (Average molecular mass 1759.0, Da), and
ACTH 18–39 clip (adenocorticotropic hormone clip 18–39,
average molecular mass 2465.199 Da). Sofware MassLynx 4.0
(Micromass); ProteinLynx 2.0 (Micromass) was used for process-
ing, background subtraction, and some supplemental analysis.
Resulting peptides were matched with their corresponding
proteins with XProteo (XProteo: fast, reliable protein identifica-
tion), by searching the non-redundant database maintained at the
NCBI (http://www3.ncbi.nlm.nih.gov/). In order to produce a
putative protein identification and score, the following parameters
were used for search: mass tolerance 0.07 Da, incomplete
cleavages allowed, alkylation of Cys and oxidation of Met were
considered as possible modifications. Percentage of sequence
coverage (%) was indicated for each protein assignment. Z-score is
defined as the distance to the population mean in unit of standard
deviation. It also corresponds to the percentile of the search in the
random match population (according to ProFound - Peptide
Mapping Version 4.10.5 - The Rockefeller University Edition).
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